HopeStage
Back to all studies
CompletedNCT01065259

Concerta or Strattera for executive skills in children with ADHD

About this titleRead the official source — NCT01065259
Medication studyAges 6–16China
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 16 years.

Listed locations
BeijingSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2008
Recruitment status
Completed
Enrollment listed in the registry
262
Sponsor
Peking University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
From 6 Years to 16 Years
Official registry ID
NCT01065259
Official title
Show the full official title

Randomized Control Study of Concerta and Strattera on the Improvement of Executive Function in Attention Deficit Hyperactivity Disorder Children

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Beijing

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Peking University, a university.

Did this study involve medication?

Yes. The study involved medication, including OROS MPH and Atomoxetine.

Who was this study for?

Listed age limits: 6 years to 16 years.

Want to explore more studies?

Explore studies